Patient management and care after primary percutaneous coronary intervention: Reinforcing a continuum of care after primary percutaneous coronary intervention

American Heart Journal

Volumn 160, Issue 6 SUPPL., 2010, Pages

  Zimarino, Marco ^a   Ruggieri, Benedetta ^a   De Caterina, Raffaele ^a  

^a UNIVERSITY OF CHIETI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTITHROMBIN; ANTIVITAMIN K; CLOPIDOGREL; CONTRAST MEDIUM; FIBRINOGEN RECEPTOR ANTAGONIST; PEXELIZUMAB; TICLOPIDINE;

ACUTE HEART INFARCTION; AEROBIC EXERCISE; ALLERGIC REACTION; ARTICLE; BLEEDING; BLOOD TRANSFUSION; BRADYCARDIA; BRAIN HEMORRHAGE; CARDIOGENIC SHOCK; CLINICAL TRIAL; CONTRAST INDUCED NEPHROPATHY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DRUG MEGADOSE; EMBOLISM; FOLLOW UP; GASTROINTESTINAL HEMORRHAGE; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART REHABILITATION; HEART RUPTURE; HEART TAMPONADE; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE SEPTUM DEFECT; HEART VENTRICLE TACHYCARDIA; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; KIDNEY EXAMINATION; KIDNEY FUNCTION; MORTALITY; ORAL BLEEDING; PATIENT ASSESSMENT; PATIENT CARE; PERCUTANEOUS CORONARY INTERVENTION; PERICARDITIS; PRIORITY JOURNAL; RECURRENT DISEASE; RETROPERITONEAL HEMATOMA; SECONDARY PREVENTION; SEPSIS; SMOKING CESSATION; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STENT THROMBOSIS; STROKE; TACHYCARDIA; THROMBUS; UNSTABLE ANGINA PECTORIS; URINARY TRACT HEMORRHAGE; VASCULAR ACCESS;

EID: 78650114642     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2010.10.015     Document Type: Article

References (37)

1. Andersen H.R., Nielsen T.T., and Rasmussen K. A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction N Engl J Med 349 2003 733 742
2. Keeley E.C., Boura J.A., and Grines C.L. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials Lancet 361 2003 13 20
3. Alexander K.P., Chen A.Y., and Roe M.T. Excess dosing of antiplatelet and antithrombin agents in the treatment of non-ST-segment elevation acute coronary syndromes JAMA 294 2005 3108 3116
4. Doyle B.J., Ting H.H., and Bell M.R. Major femoral bleeding complications after percutaneous coronary intervention: incidence, predictors, and impact on long-term survival among 17,901 patients treated at the Mayo Clinic from 1994 to 2005 JACC Cardiovasc Interv 1 2008 202 209
5. Chase A.J., Fretz E.B., and Warburton W.P. Association of the arterial access site at angioplasty with transfusion and mortality: the M.O.R.T.A.L study (Mortality benefit Of Reduced Transfusion after percutaneous coronary intervention via the Arm or Leg) Heart 94 2008 1019 1025
6. Cantor W.J., Puley G., and Natarajan M.K. Radial versus femoral access for emergent percutaneous coronary intervention with adjunct glycoprotein IIb/IIIa inhibition in acute myocardial infarction - the RADIAL-AMI pilot randomized trial Am Heart J 150 2005 543 549
7. Nikolsky E., Mehran R., and Sadeghi H.M. Prognostic impact of blood transfusion after primary angioplasty for acute myocardial infarction: analysis from the CADILLAC (Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications) Trial JACC Cardiovasc Interv 2 2009 624 632
8. Poli A., Fetiveau R., and Vandoni P. Integrated analysis of myocardial blush and ST-segment elevation recovery after successful primary angioplasty: real-time grading of microvascular reperfusion and prediction of early and late recovery of left ventricular function Circulation 106 2002 313 318
9. Sciagrà R., Parodi G., and Migliorini A. ST-segment analysis to predict infarct size and functional outcome in acute myocardial infarction treated with primary coronary intervention and adjunctive abciximab therapy Am J Cardiol 97 2006 48 54
10. Antman E.M., Hand M., and Armstrong P.W. Focused update of the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the Canadian Cardiovascular Society endorsed by the American Academy of Family Physicians: 2007 writing group to review new evidence and update the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction, writing on behalf of the 2004 writing committee Circulation 2008;117 2007 296 329
11. Van de Werf F., Bax J., and Betriu A. Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology Eur Heart J 29 2008 2909 2945
12. Tepel M., Aspelin P., and Lameire N. Contrast-induced nephropathy: a clinical and evidence-based approach Circulation 113 2006 1799 1806
13. Marenzi G., Lauri G., and Assanelli E. Contrast-induced nephropathy in patients undergoing primary angioplasty for acute myocardial infarction J Am Coll Cardiol 44 2004 1780 1785
14. Marenzi G., Assanelli E., and Marana I. N-Acetylcysteine and contrast-induced nephropathy in primary angioplasty N Engl J Med 354 2006 2773 2782
15. Mehta R.H., Starr A.Z., and Lopes R.D. Incidence of and outcomes associated with ventricular tachycardia or fibrillation in patients undergoing primary percutaneous coronary intervention JAMA 301 2009 1779 1789
16. Valeur N., Clemmensen P., and Saunamäki K. The prognostic value of pre-discharge exercise testing after myocardial infarction treated with either primary PCI or fibrinolysis: a DANAMI-2 sub-study Eur Heart J 26 2005 119 127
17. Idorn L., Høfsten D.E., and Wachtell K. Prevalence and prognostic implications of ST-segment deviations from ambulatory Holter monitoring after ST-segment elevation myocardial infarction treated with either fibrinolysis or primary percutaneous coronary intervention (a Danish Trial in Acute Myocardial Infarction-2 Substudy) Am J Cardiol 100 2007 937 943
18. De Luca G., Suryapranata H., and van 't Hof A.W. Prognostic assessment of patients with acute myocardial infarction treated with primary angioplasty: implications for early discharge Circulation 109 2004 2737 2743
19. Heggunje P.S., Harjai K.J., and Stone G.W. Procedural success versus clinical risk status in determining discharge of patients after primary angioplasty for acute myocardial infarction J Am Coll Cardiol 44 2004 1400 1407
20. Chambers C.E., Dehmer G.J., and Cox D.A. Defining the length of stay following percutaneous coronary intervention: an expert consensus document from the Society for Cardiovascular Angiography and Interventions. Endorsed by the American College of Cardiology Foundation Catheter Cardiovasc Interv 73 2009 847 858
21. Stenestrand U., Lindbäck J., and Wallentin L. Long-term outcome of primary percutaneous coronary intervention vs prehospital and in-hospital thrombolysis for patients with ST-elevation myocardial infarction JAMA 296 2006 1749 1756
22. Ho P.M., Bryson C.L., and Rumsfeld J.S. Medication adherence: its importance in cardiovascular outcomes Circulation 119 2009 3028 3035
23. Osterberg L., and Blaschke T. Adherence to medication N Engl J Med 353 2005 487 497
24. Giannuzzi P., Mezzani A., and Saner H. Physical activity for primary and secondary prevention. Position paper of the Working Group on Cardiac Rehabilitation and Exercise Physiology of the European Society of Cardiology Eur J Cardiovasc Prev Rehabil 10 2003 319 327
25. Valgimigli M., Airoldi F., and Zimarino M. Stent choice in primary percutaneous coronary intervention: drug-eluting stents or bare metal stents? J Cardiovasc Med (Hagerstown) 10 Suppl 1 2009 S17 S26
26. Mauri L., Silbaugh T.S., and Garg P. Drug-eluting or bare-metal stents for acute myocardial infarction N Engl J Med 359 2008 1330 1342
27. Steg P.G., Fox K.A., and Eagle K.A. Mortality following placement of drug-eluting and bare-metal stents for ST-segment elevation acute myocardial infarction in the Global Registry of Acute Coronary Events Eur Heart J 30 2009 321 329
28. Spertus J.A., Kettelkamp R., and Vance C. Prevalence, predictors, and outcomes of premature discontinuation of thienopyridine therapy after drug-eluting stent placement: results from the PREMIER registry Circulation 113 2006 2803 2809
29. De Caterina R., Husted S., and Wallentin L. Anticoagulants in heart disease: current status and perspectives Eur Heart J 28 2007 880 913
30. Connolly S., Pogue J., and Hart R. Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial Lancet 367 2006 1903 1912
31. Walter H., Neumann F.J., and Hadamitzky M. Coronary artery stent placement with postprocedural antiplatelet therapy in acute myocardial infarction Coron Artery Dis 9 1998 577 582
32. Ruiz-Nodar J.M., Marín F., and Lip G.Y. Antithrombotic therapy use after percutaneous coronary intervention and stent implantation in patients taking chronic oral anticoagulation JACC Cardiovasc Interv 1 2008 329
33. Sambola A., Ferreira-González I., and Angel J. Therapeutic strategies after coronary stenting in chronically anticoagulated patients: the MUSICA study Heart 95 2009 1483 1488
34. Jackevicius C.A., Li P., and Tu J.V. Prevalence, predictors, and outcomes of primary nonadherence after acute myocardial infarction Circulation 117 2008 1028 1036
35. Ho P.M., Magid D.J., and Shetterly S.M. Medication nonadherence is associated with a broad range of adverse outcomes in patients with coronary artery disease Am Heart J 155 2008 772 779
36. Zimarino M., Calafiore A.M., and De Caterina R. Complete myocardial revascularization: between myth and reality Eur Heart J 26 2005 1824 1830
37. Eisenberg M.J., Schechter D., and Lefkovits J. Utility of routine functional testing after percutaneous transluminal coronary angioplasty: results from the ROSETTA registry J Invasive Cardiol 16 2004 318 322